We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+1.34%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$42.2B
AUM Growth
-$1.23B
(-2.8%)
Cap. Flow
-$952M
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
14.57%
Holding
2,171
New
150
Increased
772
Reduced
960
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$156M |
| 2 |
Prologis
PLD
|
+$150M |
| 3 |
Chevron
CVX
|
+$109M |
| 4 |
Qualcomm
QCOM
|
+$101M |
| 5 |
Paycom
PAYC
|
+$90.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
+$230M |
| 2 |
Kimberly-Clark
KMB
|
+$160M |
| 3 |
Stanley Black & Decker
SWK
|
+$130M |
| 4 |
Paychex
PAYX
|
+$113M |
| 5 |
Dominion Energy
D
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.81% |
| 2 | Healthcare | 17.11% |
| 3 | Financials | 12.73% |
| 4 | Industrials | 9.87% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
OmniAb
OABI
$632M
| $18.3K | ﹤0.01% |
4,881
-2
| -0% | -$9 |
|
1727
Petrobras
PBR
$140B
| $17.9K | ﹤0.01% |
1,238
-206
| -14% | -$3.2K |
|
1728
Henry Schein
HSIC
$9.75B
| $17.9K | ﹤0.01% |
279
-387
| -58% | -$27.2K |
|
1729
Lyell Immunopharma
LYEL
$267M
| $16.9K | ﹤0.01% |
584
+49
| +9% | +$2.33K |
|
1730
ZipRecruiter
ZIP
$317M
| $16.9K | ﹤0.01% |
1,861
+97
| +5% | +$979 |
|
1731
Urban Edge Properties
UE
$2.55B
| $16.9K | ﹤0.01% |
+915
| New | +$15.7K |
|
1732
Lands' End
LE
$303M
| $16.6K | ﹤0.01% |
+1,218
| New | +$16.4K |
|
1733
American States Water
AWR
$3.43B
| $16.5K | ﹤0.01% |
228
+157
| +221% | +$11.3K |
|
1734
Nasdaq
NDAQ
$49.9B
| $16.4K | ﹤0.01% |
272
-252
| -48% | -$15.3K |
|
1735
Embecta
EMBC
$288M
| $16.3K | ﹤0.01% |
1,307
+407
| +45% | +$4.94K |
|
1736
St. Joe Company
JOE
$3.66B
| $16.2K | ﹤0.01% |
+296
| New | +$16.7K |
|
1737
Janus International
JBI
$607M
| $16.1K | ﹤0.01% |
+1,276
| New | +$17.8K |
|
1738
T. Rowe Price
TROW
$22.2B
| $15.7K | ﹤0.01% |
136
-39
| -22% | -$4.49K |
|
1739
Worthington Enterprises
WOR
$2.66B
| $15.7K | ﹤0.01% |
331
+4
| +1% | +$226 |
|
|
DAY
1740
DELISTED
Dayforce
DAY
| $15.4K | ﹤0.01% |
310
-72,028
| -100% | -$4.12M |
|
1741
Group 1 Automotive
GPI
$3.28B
| $15.2K | ﹤0.01% |
51
+18
| +55% | +$5.33K |
|
1742
Shinhan Financial Group
SHG
$38.8B
| $14.9K | ﹤0.01% |
428
+99
| +30% | +$3.33K |
|
1743
Merit Medical Systems
MMSI
$5.15B
| $14.8K | ﹤0.01% |
172
-12
| -7% | -$944 |
|
1744
Opendoor
OPEN
$2.57B
| $14.6K | ﹤0.01% |
8,178
+6,326
| +342% | +$13.6K |
|
1745
Redwire
RDW
$2.69B
| $14.5K | ﹤0.01% |
2,027
+1,924
| +1,868% | +$9.26K |
|
|
CCC
1746
CCC Intelligent Solutions
CCC
$3.89B
| $14.4K | ﹤0.01% |
1,295
-72
| -5% | -$820 |
|
1747
First Guaranty Bancshares
FGBI
$139M
| $14.4K | ﹤0.01% |
1,595
| – | – |
|
|
ZEUS
1748
DELISTED
Olympic Steel
ZEUS
| $14.3K | ﹤0.01% |
320
-64
| -17% | -$3.66K |
|
1749
Norwegian Cruise Line
NCLH
$6.56B
| $14.3K | ﹤0.01% |
763
-220
| -22% | -$3.86K |
|
1750
Annexon
ANNX
$743M
| $14.1K | ﹤0.01% |
2,882
+1,599
| +125% | +$8.27K |
|
Similar funds
Federated Hermes's Q2 2024 Portfolio in Review
As of Q2 2024, Federated Hermes held 2,171 positions worth $42.2B, down 2.8% from $43.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes's Q2 2024 filing shows 150 new, 772 increased, 960 reduced and 152 closed positions. Its largest new stake was Loar Holdings: 729,296 shares worth $39M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Federated Hermes's largest Q2 2024 buy was Loar Holdings: 729,296 shares worth $39M.
- Federated Hermes added most to Bristol-Myers Squibb in Q2 2024, an estimated $156M increase.
- Federated Hermes's biggest Q2 2024 reduction was Kimberly-Clark, cutting an estimated $160M.
- Federated Hermes fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $230M.
- Federated Hermes's ten largest holdings make up 15% of its $42.2B portfolio in Q2 2024.
- Federated Hermes opened 150 new positions and closed 152 in Q2 2024.
- Federated Hermes's portfolio value fell 2.8% quarter-over-quarter to $42.2B.
Based on Federated Hermes's 13F filing for Q2 2024, filed 8 Aug 2024.